INTRODUCTION
©2007 Poultry Science Association Inc. Received December 28, 2006 . Accepted February 10, 2007 Campylobacter is a human foodborne pathogen that has been associated with poultry and poultry meat products. The Centers for Disease Control and Prevention has identified campylobacteriosis as one of the most common foodborne bacterial diseases in recent years (CDC, 2006) .
Campylobacter generally enters the processing plant with the live broilers . Although modern broiler processing is very effective in lessening the numbers of this pathogen, it can be found on fully processed carcasses postchill (Berrang and Dickens, 2000) .
It was first noted in the 1940s that low doses of antimicrobial drugs could increase the rate of broiler growth (Jones and Ricke, 2003) . This approach was adopted by much of the industry to maximize production and maintain a low-cost product. Many drugs are available for use as broiler feed additives without a prescription (Jones and Ricke, 2003) . Some reports suggest that in addition did not affect Campylobacter numbers on carcasses after drugs and cross-resistance between these antimicrobials inside-outside washing (3.11 and 3.07 log cfu/mL of occurs. Commercial broiler chicks were placed in isolation rinse). However, carcasses of broilers fed tylosin phosgrow-out chambers and colonized with Campylobacter jephate had lower numbers of Campylobacter after chilling juni. From 14 d of age through grow-out, broilers were (1.45 log cfu/mL of rinse) than control carcasses (2.31 log fed ad libitim a diet that included 22 ppm of tylosin cfu/mL of rinse There is specific evidence that Campylobacter exposed to macrolide drugs can become resistant, gaining the ability to grow in the presence of the drug (Aarestrup et aI., 1997) .
Macrolide resistance in Campylobacter is a very stable trait, being maintained for many generations even without continuous antimicrobial pressure (Gibreel et aI., 2005; Kim et aI., 2006) . Campylobacter that have become resistant to macrolides are a concern for human health because the usual drug of choice to treat human campylobacteriosis is also a macrolide, erythromycin (Kim et aI., 2006 
MATERIALS AND METHODS

Experimen.tal Overview
Day-of-hatch commercial broiler chicks were exposed to penmates previously inoculated with macrolide-susceptible Campylobacter. At 14 d of age, treated birds began to receive feed containing a subtherapeutic level of tylosin phosphate (20 g/ton). Control birds received a nonmedicated feed. At 42 d of age, all birds were slaughtered and processed in a pilot processing plant that closely simulated commercial conditions. Ten whole carcass rinses were collected after defeathering, after inside-outside washing, and after immersion chill. Campylobacter resistant to and sensitive to erythromycin were enumerated from rinses, and the numbers from treated birds were compared with those from carcasses of birds that had been fed the control diet. Three replications were conducted.
Broilers and Housing
In each of 3 replicate trials, straight run day-of-hatch chicks were obtained from a commercial broiler hatchery and were allotted to 1 of 2 groups of 35 birds each. Chicks were placed in separate isolation rooms that had been sanitized and outfitted with fresh pine shaving litter. Chicks were provided a standard nonmedicated broiler starter-grower diet and water ad libitum. All procedures were administered in accordance with protocols approved by an institutional animal care and use committee.
Inoculum and Campylobacter Colonization
At placement, birds were exposed to.Campylobacter jejuni by comingling with 2 seeder chicks that had been challenged by oral gavage with 10 7 cfu of a 3-strain cocktail of C jejuni. Seeder birds were marked at challenge and were not included in sample collection.
All strains used in these studies were selected from the National Antimicrobial Resistance Monitoring SystemEnteric Bacteria (NARMS) Campylobacter collection at the USDA-Agricultural Research Service Russell Research Center in Athens, Georgia. The strains used were originally isolated from poultry carcass rinses. Previous antim icrobial resistance testing had determined that the isolates were susceptible to azithromycin, erythromycin, ciprofloxacin, clindamycin, chloramphenicol, gentamicin, nalidixic acid, and tetracycline. Challenge cultures were prepared by subculturing frozen stock cultures of each strain onto blooq agar (tryptic soy agar with 5% sheep blood, Becton-Dickinson, Sparks, MD) and incubating at 42°C for 24 h in a sealable bag flushed with a microaerobic gas mixture (5% O 2 ,10% CO 2 , and 85% N 2 ). Freshly grown colonies of each of the 3 strains were suspended as a mixture in sterile PBS (0.9%, pH 7.2) and adjusted to a final concentration of 10 8 cfulmL using an absorbance of 0.45 at 540 nm (Spectronic 20, Spectronics Instruments Inc., Rochester, NY). Inoculum concentrations were confirmed by spread plating serial dilutions of each inoculum in duplicate.
Feed Treatments
At 14 d of age, tylosin phosphate (Tylan 10, Blanco Animal Health, Indianapolis, IN) was administered in the diet of experimental birds at a subtherapeutic concentration of 22 ppm (20 g/ton). This is an FDA-approved level for increased rate of weight gain and improved feed efficiency in broilers and is in accordance with the manufacturer's label directions. Tylosin medicated feed was provided ad libitum to this group of broilers for the remainder of the study (4 wk). Untreated control broilers continued to receive nonmedicated feed for the remainder of grow-out.
Processing
At 42 d of age, all broilers were subjected to a feed withdrawal period of 12 h. Broilers were then caged in plastic coops, transported to a pilot processing facility, and hung in groups of 10 in commercial-style shackles. Control broilers were processed first. All broilers were stunned electrically with 12 V DC (Stunner model SF-7000, Simmons Engineering Co., Dallas, GA) and killed by cutting blood vessels in the neck with an automated killing machine (Killer model SK.5, Simmons Engineering Co.). Carcasses were scalded in a set of 3 triple-pass scald tanks (Scald Tank model SGS-3CA, Stork Gamco, Gainesville, GA) set at 56°C. Shackle speed was set so that carcasses spent 30 s in each scald tank with 30 s in between. Carcasses then proceeded into a commercial defeathering machine (Picker model d-8, Stork Gamco) operated with a tap water spray (average total chlorine of 0.5 ppm).
Carcasses were removed from the kill line, the feet were removed, necks were broken, and carcasses were rehung on an evisceration line. Carcasses proceeded through a commercial style venter-opener (model v I 0 164, Stork Gamco), evisceration machine (model PNT-24, Stork Gamco), and inside-outside washer (model MBW-16, Stork Gamco) using tap water set at 80 psi. Carcasses were removed from shackles and placed in pilot-scale agitated chill tanks (one tank for control carcasses and another for treated carcasses) filled with ice and tap water. Carcasses remained in the chill tank with agitation for 45 min. In between the control and treated broilers, the processing equipment was thoroughly cleaned using a hose and 52°C water. Broilers fed medicated feed were processed using the same methods and equipment as described above, except that a separate pilot-scale chiller was used.
Sampling and Campylobacter Culture
Ten carcasses from each treatment were collected for sampling after feather removal, after inside and outside washing, and after chilling. Carcasses were placed in sterile plastic bags and subjected to a 60-s low volume wholecarcass rinse procedure (Cox et al., 1981) using PBS as the diluent. Serial dilutions were prepared in PBS and plated onto duplicate Campy-Cefex agar (CCA; Stern et al., 1992) and Campy-Cefex agar supplemented with 8 fLg/mL of erythromycin (CCAE). All plates were incubated at 42°C for 48 h in a microaerobic atmosphere. Total and resistant populations of Campy10bacter were estimated by plate counts on CCA and CCAE, respectively.
Colonies characteristic of Campy10bacter were counted. Presumptive Campy10bacter colonies for each sample were selected from CCA and CCAE plates for confirmation and susceptibility testing. All colony types found in each sample were confirmed as members of the genus Campy1o-bacter by observation of cellular morphology and motility under phase-contrast microscopy. All colony types were further confirmed using a latex agglutination serological test (Microgen Bioproducts Ltd., Camberly, UK).
Antimicrobial Resistance Measurement
The minimum inhibitory concentrations (MIC) of erythromycin for all Campy10bacter isolates recovered from individual carcass rinse samples were determined using the agar dilution method recommended by the Clinical and Laboratory Standards Institute (NCCLS, 2002) . Erythromycin is recommended for macrolide susceptibility testing of Campy1obacter, because interpretive standards for tylosin susceptibility testing have not been established. Nine doubling concentrations of erythromycin (Sigma, St. Louis, MO) were tested (range, 1 to 256 fLg/mL) using Mueller-Hinton agar containing 5% defibrinated sheep blood. Isolates were tested on duplicate plates incubated at 42°C for. 24 h under microaerobic conditions and were considered resistant to erythromycin if the MIC was ;:::8 fLg/mL (NCCLS, 2002) . Campy10bacter jejuni ATCC 33560 was used as a quality-control strain, and its erythromycin MIC remained 1 fLg/ mL throughout the study, which falls within the Clinical and Laboratory Standards Institute recommended range (1 to 4fLg/mL) under the growth conditions described (NCCLS, 2002) .
Statistical Analysis
Campy10bacter counts were transformed to log colonyforming units per milliliter of carcass rinse. A GLM analysis was conducted using a complete randomized block design with replication as the block. Means were separated with a Tukey's honest significant difference test. Student's t-test was used to compare MIC values. All analyses were conducted using the Statistica software package (StatSoft Inc., Tulsa OK).
RESULTS
The numbers of Campy10bacter recovered from wholecarcass rinses collected during processing· are shown in Table 1 . Feed containing tylosin phosphate had no effect on the number of Campy10bacter detected per milliliter of rinse for carcasses examined immediately following defeathering or the inside-outside washer. However, carcasses from the broilers fed tylosin had lower numbers of Campy10bacter per milliliter of rinse after chilling than did control carcasses from nonmedicated broilers.
No Campy10bacter were detected on the CCAE plates from carcasses of broilers fed nonmedicated feed. However, the numbers of Campy10bacter detected on carcasses fed tylosin phosphate were the same on CCAE as on plain CCA. This suggests that virtually all the Campy10bacter detected on carcasses from medicated birds were in fact resistant to erythromycin, whereas none of the Campy1o-bacter from control birds were.
Minimum inhibitory concentrations of erythromycin and tylosin were determined for Campy10bacter from control and treated broilers. All Campy10bacter isolates from carcasses of control broilers were susceptible to erythromycin, with MIC values of 1 fLg/mL. Tylosin phosphate MIC values for Campy10bacter from control broilers ranged from 2 to 16 fLg/mL; 8 fLg/mL was the most common MIC.
Campy10bacter isolates from carcasses of broilers fed the medicated feed showed resistance to both drugs. Campy10-bacter from test carcasses were isolated on both CCA and CCAE plates. Isolates from CCA plates had a range of MIC values for erythromycin ranging from 8 (3 isolates) to >256 (16 isolates), with most of the isolates (36) having MIC values of 128. Tylosin MIC ranged from 32 to >256. Higher MIC values were observed for isolates recovered from CCAE than from plain CCA (P < 0.01). For isolates from CCAE, an MIC of 256 was the most common value for erythromycin; for tylosin, all isolates from CCAE had MIC values of >256.
DISCUSSION
Reports in the literature suggest that there may be an overall fitness cost associated with antimicrobial resistance (Andersson and Levin, 1999) . In other words, in the a--€Values with no like superscripts are different (P < 0.05) by Tukey's honestly significant difference test. On carcasses from broilers fed medicated feed, Campylobacter numbers on Campy-Cefex agar (CCA) with the addition of 8 fLg/mL of erythromycin (CCAE) were not different than those from the same sample site on CCA by Student's t-test (P < 0.01).
lOnly allows growth of resistant Campylobacter. 220 g/ton of tylosin phosphate. 3None detected, <1 cfu/mL (0 log cfu/mL).
process of becoming drug resistant, a bacterial cell may gain or lose other traits, resulting in less vigor under conditions other than drug pressure. The current data
show that compared with wild-type Campylobacter on control carcasses, there were lower numbers of resistant
Campylobacter on chilled carcasses of broilers fed tylosin.
Further studies are warranted to determine whether resistance to erythromycin carries a fitness price, changing the ability of Campylobacter to adhere to broiler carcasses or survive immersion chilling. In this study, CCAE included 8 /-Lg of erythromycin/ mL, which is the break point at which an organism is considered resistant to this drug. Therefore, anything that grows on CCAE would be considered resistant to erythromycin. There is no established break point for tylosin; however, these 2 drugs are closely related, and when
Campylobacter is resistant to erythromycin, it would be expected to be resistant to tylosin also. The current data show that Campylobacter-positive broilers fed subtherapeutic levels of tylosin will result in processed carcasses with erythromycin-resistant Campylobacter. Because erythromycin is often used to treat human campylobacteriosis, these results may be cause for concern.
Some researchers, although fully recognizing the development of drug resistance in bacterial pathogens, feel that this represents a low risk to the human consumer of meat animals. Phillips et al. (2004) suggest that because cooking kills human pathogens associated with food animals, the risk of disease or complicated treatment is low. A published deterministic model suggests that tylosin use in food animals would lead to a very low probability of treatment failure (lout 10 million; Hurd et aI., 2004) . Another study reports that removing macrolides from animals would actually result in more human disease caused by increased disease in animals (Cox and Popken, 2006) .
The question of subtherapeutic antimicrobial use in meat animal production is complex. Macrolide resistance is a stable trait, likely to be maintained by Campylobacter for many generations, even without continued exposure to the drug. The possibility exists that resistant Campylobacter from poultry could contaminate kitchens, maintain its resistant trait, and become increasingly prevalent in the environment in general. Treatment of human campylobacteriosis is relatively rare, because most people with diarrhea do not seek medical attention. Nevertheless, in those instances when the most susceptible members of the population become ill and treatment is sought, resistance could have an impact on the likelihood of success. Indeed, infection with drug-resistant Campylobacter has been found to be related to a higher incidence of invasive disease or death than infection with susceptible Campylobacter (Helms et aI., 2005) . Industry and consumers alike will benefit from continued studies and discussion to clarify the impact of subtherapeutic antimicrobial use in poultry production.
